CapsoVision CV
NASDAQ CV
$5.91 -0.21 (-3.43%)
At close: Aug 20, 2026 · 4:00 PM EDT

CapsoVision (CV) Liabilities and Shareholders Equity (2024 - 2026)

CapsoVision (CV) posted Liabilities and Shareholders Equity of $18.2 million for Q4 2025, down 29.22% sequentially from $25.7 million in Q3 2025, and up 8.1% YoY from $16.8 million in Q4 2024.

CapsoVision (CV) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends

CapsoVision has reported Liabilities and Shareholders Equity for 2 years, with the latest figure at $18.2 million in Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 8.1% year-over-year to $18.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $70.2 million (changed N/A YoY) and the FY2025 annual result came in at $18.2 million, up 8.1% from the prior year.
  • Liabilities and Shareholders Equity retreated to $18.2 million in Q4 2025 per CV's latest filing, from $25.7 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $25.7 million in Q3 2025 and troughed at $9.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 109.22 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 31.04 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 10.74 Bn
10 CapsoVision 295.13 Mn 286.05 Mn 1.87 Mn 18.57 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 18.57 Mn
Dec 31, 2025 18.16 Mn
Sep 30, 2025 25.66 Mn
Jun 30, 2025 9.55 Mn
Dec 31, 2024 16.80 Mn